Trials / Completed
CompletedNCT00195780
A Study for the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents
An Open-Label Study to Evaluate the Safety of Depakote ER in the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 227 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 10 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the long-term safety profile of the Investigational Medication Depakote ER in the treatment of Bipolar I Disorder, manic or mixed episode, in children and adolescents ages 10-17.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Divalproex Sodium (Depakote ER) |
Timeline
- Start date
- 2005-02-01
- First posted
- 2005-09-20
- Last updated
- 2007-07-02
Locations
29 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00195780. Inclusion in this directory is not an endorsement.